ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Clinical trials for ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo aims to shrink tough lung tumors
Disease control Not yet recruitingThis study tests a combination of two experimental drugs, AMT116 and ivosimab, in people with advanced non-small cell lung cancer that cannot be removed by surgery. The goal is to find a safe dose and see if the combo can shrink tumors. About 118 adults aged 18 to 75 will take pa…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE1, PHASE2 • Sponsor: Multitude Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 02:20 UTC
-
Could a common antioxidant boost chemo for lung cancer?
Disease control Not yet recruitingThis study tests whether adding alpha lipoic acid (a natural antioxidant) to standard chemotherapy helps adults with advanced non-small cell lung cancer. The goal is to see if it improves tumor response, survival, and quality of life while reducing side effects. About 60 particip…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated May 26, 2026 02:19 UTC
-
Personalized infusion timing may boost lung cancer treatment
Disease control Not yet recruitingThis study tests whether giving immunotherapy and chemotherapy at different times, based on daily immune system monitoring, works better than giving them together. 246 adults with advanced non-small cell lung cancer will be assigned to one of three timing schedules. The goal is t…
Matched conditions: ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated May 26, 2026 02:12 UTC